| Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists | |
| Liu, Zhen; Jiang, Xiaobing; Gao, Liang; Liu, Xuan; Li, Jiali; Huang, Xing; Zeng, Tao | |
| 刊名 | WORLD NEUROSURGERY
 |
| 2019 | |
| 卷号 | 128 |
| 关键词 | Dopamine D2 receptor Glioblastoma Synergy Temozolomide |
| ISSN号 | 1878-8750 |
| DOI | 10.1016/j.wneu.2019.04.180 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4215632 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Liu, Zhen,Jiang, Xiaobing,Gao, Liang,et al. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists[J]. WORLD NEUROSURGERY,2019,128. |
| APA | Liu, Zhen.,Jiang, Xiaobing.,Gao, Liang.,Liu, Xuan.,Li, Jiali.,...&Zeng, Tao.(2019).Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.WORLD NEUROSURGERY,128. |
| MLA | Liu, Zhen,et al."Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists".WORLD NEUROSURGERY 128(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论